Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal Pain in Cancer Patients,

ConditionPerineal Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAssiut University

About this trial

Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

American Society of Anesthesiology physical status of I or III (ASA), of both sex

cancer-related anal or perineal pain

Disqualifiers

coagulopathies

allergies to the contrast dye

patients with moderate or significant cardiac/respiratory disease or hepatic

Trial design

Design model

Parallel

Treatments tested in this trial

  • US assisted caudal epidural pulsed radiofrequency

    Procedure/Surgery

    patients will receive US assisted caudal epidural pulsed radiofrequency and followed up to 8 weeks

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: ultrasound (US) assisted caudal epidural pulsed radiofrequencyActive comparator 1 intervention
Group B: conventional medical treatmentNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

visual analog scale (VAS) score 4 weeks post-intervention

Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks

Time frame
8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.